| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/05/2007 | WO2007037514A1 Novel application of heparin-binding epidermal growth factor-like growth factor for medical purposes |
| 04/05/2007 | WO2007037473A1 Method of inhibiting cell migration and cell migration inhibitor |
| 04/05/2007 | WO2007037333A1 Inhibitor of binding to non-typical proline-rich sequence |
| 04/05/2007 | WO2007037299A1 Substance inhibiting the expression of hb24 or the transcriptional regulatory activity thereof, use of the same and method of screening the substance |
| 04/05/2007 | WO2007037297A1 Composition effective for prevention and treatment of adult disease |
| 04/05/2007 | WO2007037265A1 Dna vaccine composition |
| 04/05/2007 | WO2007037245A1 Polypeptide having anti-angiogenic activity |
| 04/05/2007 | WO2007037133A1 Method for evaluation of compound capable of acting on plk3 |
| 04/05/2007 | WO2007036945A2 Hepatocyte growth factor receptor splice variants and methods of using same |
| 04/05/2007 | WO2007036732A1 Imidazo [1,2-a] pyridine having anti-cell-proliferation activity |
| 04/05/2007 | WO2007036717A1 4- (4-BROMO-2-FLUOROANILINO) -6-METHOXY-7- (l-METHYLPIPERIDIN-4 -YLMETHOXY) QUINAZOLINE MONOHYDRATE |
| 04/05/2007 | WO2007036638A1 Cd4+ t survivin epitopes and uses thereof |
| 04/05/2007 | WO2007036131A1 Carzole sulphamide derivatives and their preparation method |
| 04/05/2007 | WO2007036074A1 The use of phthalide derivatives |
| 04/05/2007 | WO2007036053A1 Inhibitors of ste20-like kinase (slk) and methods of modulating cell cycle progression and cell motility |
| 04/05/2007 | WO2007021825A3 Treatment of proliferative disorders |
| 04/05/2007 | WO2007020386A3 Apoe mimetic agents |
| 04/05/2007 | WO2007009724A3 Cycloalkane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 04/05/2007 | WO2007009723A3 Azepane- or azocane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 04/05/2007 | WO2006125645A3 Inhibitors of mmp-15 in cancer treatment |
| 04/05/2007 | WO2006124874A3 Inhibitors of b-raf kinase |
| 04/05/2007 | WO2006124684A3 Combination therapy comprising a taxane and a thymidylate synthase inhibitor |
| 04/05/2007 | WO2006110594A3 Sema4d in cancer diagnosis, detection and treatment |
| 04/05/2007 | WO2006094384B1 Use of interleukin 17e for the treatment of cancer |
| 04/05/2007 | WO2006089406A8 Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agents |
| 04/05/2007 | WO2006084030B1 Small-molecule hsp90 inhibitors |
| 04/05/2007 | WO2006059121A3 Modulators of spindle checkpoint kinases and a taxol |
| 04/05/2007 | WO2006056695A8 Bengamides with a substituted caprolactame cycle, method for the preparation thereof, compositions containing them and use thereof |
| 04/05/2007 | WO2006037979A3 Nanoparticles comprising antigens and adjuvants and immunogenic structure |
| 04/05/2007 | WO2003070751A3 Partial peptide mimetics and methods |
| 04/05/2007 | US20070078142 Treatment of tuberous sclerosis associated neoplasms |
| 04/05/2007 | US20070078106 A 5-substituted uracil or 5,6-dihydro-5-substituted uracil, potentiate 5-fluorouracil; 5-substituent is selected from bromo, ido, cyano, halo-substituted C1-4 alkyl, C2-6 alkenyl, 1-halo-C2-6 alkenyl andhalo-substituted C2-6 alkynyl; antitumor agents; anticarcinogenic agents |
| 04/05/2007 | US20070078104 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis; antiinflammatory agents |
| 04/05/2007 | US20070078091 Pharmaceutical combinations for compensating for a testosterone deficiency in men while simultaneously protecting the prostate |
| 04/05/2007 | US20070078088 Methods and compositions for treating cancer using 140, 1470, 1686, 2089, 2427, 3702, 5891, 6428, 7181, 7660, 25641, 69583, 49863, 8897, 1682, 17667, 9235, 3703, 14171, 10359, 1660, 1450, 18894, 2088, 32427, 2160, 9252, 9389, 1642, 85269, 10297, 1584, 9525, 14124, 4469, 8990, 2100, 9288, 64698, 10480, 20893, 33230, 1586, 9943, 16334, 68862, 9011, 14031, 6178, 21225, 1420, 32236, 2099, 2150, 26583, 2784, 8941, 9811, 27444, 50566 or 66428 molecules |
| 04/05/2007 | US20070078076 Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| 04/05/2007 | US20070077627 Zcytor17 ligand cytokine; immunostimulators system, and proliferation and/or development of hematopoietic cells in vitro and in vivo; transcription, gene expression, culturing; anticarcinogenic and antiinflammatory agents; diabetes, pancreatitis, inflammatory bowel disease; autoimmune diseases |
| 04/05/2007 | US20070077597 Method for identifying modulators of G protein coupled receptor signaling |
| 04/05/2007 | US20070077273 Microfabricated nanopore device for sustained release of therapeutic agent |
| 04/05/2007 | US20070077244 Inhibitor protein of the wnt signal pathway |
| 04/05/2007 | US20070077242 Tumor necrosis factor specific immunoglobulin for use in treatment and prevention of tumor disorder; tissue targeted therapy |
| 04/05/2007 | US20070077226 Gutless adenovirus vector and the construction method thereof |
| 04/05/2007 | US20070077199 Humanized collagen antibodies and related methods |
| 04/05/2007 | US20070077197 Cancer diagnosis; antitumor agents, radiotherapy |
| 04/05/2007 | DE60124600T2 Zusammensetzungen und Verfahren zur Behandlung von Zuständen, die auf Östrogen ansprechen Compositions and methods for treating conditions responsive to estrogen |
| 04/05/2007 | CA2624535A1 Hepatocyte growth factor receptor splice variants and methods of using same |
| 04/05/2007 | CA2624498A1 Cd4+ t survivin epitopes and uses thereof |
| 04/05/2007 | CA2624150A1 The use of phthalide derivatives |
| 04/05/2007 | CA2623646A1 4- (4-bromo-2-fluoroanilino) -6-methoxy-7- (1-methylpiperidin-4 -ylmethoxy) quinazoline monohydrate |
| 04/05/2007 | CA2623374A1 Imidazo [1,2-a] pyridine having anti-cell-proliferation activity |
| 04/05/2007 | CA2623357A1 Inhibitors of ste20-like kinase (slk) and methods of modulating cell cycle progression and cell motility |
| 04/05/2007 | CA2623236A1 Human monoclonal antibodies to cd70 |
| 04/05/2007 | CA2590401A1 Adoptive immunotherapy with enhanced t lymphocyte survival |
| 04/05/2007 | CA2522411A1 Compositions and methods for cancer treatment |
| 04/04/2007 | WO2007041637A2 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
| 04/04/2007 | EP1770161A2 BMP-11 compositions |
| 04/04/2007 | EP1770099A1 Method of producing a modified (poly)peptide |
| 04/04/2007 | EP1769806A2 Vaccine against HPV |
| 04/04/2007 | EP1769805A1 Therapeutic modulation of the tumor inflammatory response |
| 04/04/2007 | EP1769800A2 Estrogen replacement therapy |
| 04/04/2007 | EP1769795A2 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers |
| 04/04/2007 | EP1768992A1 Neoglycorandomization and digitoxin analogs |
| 04/04/2007 | EP1768982A2 Pyrolo [2,3-d] pyrimidines that modulate ack1 and lck activity |
| 04/04/2007 | EP1768981A1 Novel pyridodihydropyrazinones method for production and use thereof as medicaments |
| 04/04/2007 | EP1768979A1 Octahydropyrrolo[2, 3, c]pyridine derivatives and pharmaceutical use thereof |
| 04/04/2007 | EP1768978A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 04/04/2007 | EP1768966A1 Coumpounds and methods for inhibiting the interaction of bcl proteins with binding partners |
| 04/04/2007 | EP1768964A1 Quinazoline modulators of hepatocyte growth factor / c-met activity for the treatment of cancer |
| 04/04/2007 | EP1768963A2 Cancer treatment method |
| 04/04/2007 | EP1768960A1 Sulfonamide derivatives |
| 04/04/2007 | EP1768956A1 Amide derivatives as inhibitors of histone deacetylase |
| 04/04/2007 | EP1768951A2 Non-natural amino acids |
| 04/04/2007 | EP1768945A1 Substituted hydroxyacetophenon derivatives |
| 04/04/2007 | EP1768707A2 Cellular receptors utilized as carrier agents for pharmaceutical compounds used in tumor imaging and cancer treatment |
| 04/04/2007 | EP1768699A1 Induction of apoptosis in toll-like receptor expressing tumor cells |
| 04/04/2007 | EP1768679A1 MODULATION OF GSK-3&bgr; AND METHOD OF TREATING PROLIFERATIVE DISORDERS |
| 04/04/2007 | EP1768671A2 Use of ecteinascidin in the treatment of cancer in patients with low level of brca1 |
| 04/04/2007 | EP1768662A2 Small molecule immunopotentiators and assays for their detection |
| 04/04/2007 | EP1556387B1 Substituted benzol e| 1,4| oxazino 3,2-g| isoindole derivatives, method for preparing same and pharmaceutical compositions containing same |
| 04/04/2007 | EP1532135B1 Nf-kb inhibitors |
| 04/04/2007 | EP1472246B1 Oxadiazoles having antiproliferative activity |
| 04/04/2007 | EP1414858B1 Single chain camelid vhh antibodies, method for their production in a mammal, and their uses |
| 04/04/2007 | EP1383501B1 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 04/04/2007 | EP1383447A4 Stent-based delivery of statins to prevent restenosis |
| 04/04/2007 | EP1362033B1 Pyridine matrix metalloproteinase inhibitors |
| 04/04/2007 | EP1352056B1 Polypeptides capable of eliciting an immune reaction against cancer |
| 04/04/2007 | EP1332139B1 Anticancer agents based on regulation of protein prenylation |
| 04/04/2007 | EP1331932B1 Use of xestospongin c for treating or preventing hiv infection |
| 04/04/2007 | EP1259595B1 Integrin antagonists |
| 04/04/2007 | EP1224172B1 Drugs for the treatment of malignant tumours |
| 04/04/2007 | EP1117393B1 L-acetylcarnitine as antitumour agent |
| 04/04/2007 | CN1942767A Gastric inhibitory polypeptide diagnostic test for detecting susceptibility to type-2 diabetes, impaired glucose tolerance, or impaired fasting glucose |
| 04/04/2007 | CN1942588A Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/04/2007 | CN1942581A Antibody with osteoclast-related protein as target |
| 04/04/2007 | CN1942475A Substituted thieno - and thiazolo - [2, 3-d] pyridines as inhibitors of Tie2 |
| 04/04/2007 | CN1942473A Process for producing pentacyclic taxane |
| 04/04/2007 | CN1942472A Reverse-turn mimetics and method relating thereto |
| 04/04/2007 | CN1942470A Akt活性抑制剂 Akt activity inhibitor |
| 04/04/2007 | CN1942464A Novel piperidine substituted diaminothiazoles |
| 04/04/2007 | CN1942463A 2-aminopyridine derivative |